Calliditas: despite weaker Q1 sales, patient enrolment is showing steady progress and is key at this stage
Tarpeyo Q1 2024 sales reached SEK278.3m (USD28m), representing a 20% decrease vs the previous quarter, primarily due to the cyberattack that Change Healthcare (part of the United Group) suffered in February 2024, which lead to disruptions in claim processing (approx. USD4.7m). As such, some of Q1 s
Since 1996, Bryan, Garnier & Co has been growing with an absolute conviction that the investment banking landscape would experience a major revolution: most of the large local generalist banking groups will disappear to the benefit of a handful of global powerhouses, and an emerging group of independent, highly specialised boutique investment banks.
Unfortunately, this report is not available for the investor type or country you selected.
Browse all ResearchPool reportsReport is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.